Puissance Life Science Opportunities Fund VI, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), bought 4,326 shares at $1.13 ($5K) on 2018-11-29, disclosed to the SEC on 2018-12-03.
Open-market purchase of $5k TCON by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.